Status:
COMPLETED
Minimally Invasive Sensing of Beta-lactam Antibiotics
Lead Sponsor:
Imperial College London
Conditions:
Healthy Volunteers
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
This study is an in-house feasibility study of a microneedle biosensor developed within Imperial College London.
Detailed Description
Outline of the study: This study will comprise the recruitment of 10-15 healthy volunteers. They will be recruited to test the microneedle biosensors and undergo rich plasma sampling with or without ...
Eligibility Criteria
Inclusion
- Adult \>18 years old
- Healthy with no evidence of active infection
- Previously received penicillin with no adverse effects
Exclusion
- High risk of skin soft tissue infection or local skin and soft tissue infection near sensor site
- Previous history of allergies to adhesive strips or active dermatitis
- Penicillin allergy or previous adverse event whilst receiving penicillin
- Anaemia on screening bloods (defined as haemoglobin \<13 g/dL in males and \<12 g/dL in females)
Key Trial Info
Start Date :
April 12 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 10 2018
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT03847610
Start Date
April 12 2018
End Date
August 10 2018
Last Update
March 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NIHR Imperial CRF
London, United Kingdom, W12 0HS